penfluridol has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ranjan, A; Srivastava, SK | 1 |
| Ranjan, A; Srivastava, SK; Wright, S | 1 |
2 other study(ies) available for penfluridol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Penfluridol; Phosphorylation; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2017 |
Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glioblastoma; Humans; Immunomodulation; Macrophages; Mice; Myeloid-Derived Suppressor Cells; Penfluridol; Spleen; T-Lymphocytes, Regulatory; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |